Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.43 |
| ▸ | HK2 | P52789 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 3/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | SNCA | P37840 | 1/20 | 0.39 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.39 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.39 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57764 | 0.83 | MAOA (0.52) | MAOAMAOBHSD17B3PDE4BCDC25B | |
| SCHEMBL25834313 | 0.82 | CYP2D6 (0.48) | HSD17B3MAPTHTTALDH1A1NPSR1 | |
| Ammonia Solution, Strong SCHEMBL634924 | 0.80 | MAOA (0.50) | MAOAMAOBHSD17B3PDE4BCDC25B | |
| SCHEMBL14407340 | 0.78 | PDE4B (0.53) | MAOAMAOBHSD17B3PDE4BHK2 | |
| SCHEMBL25834311 | 0.78 | PTPRC (0.39) | MAOAMAOBHSD17B3MAPTHTT | |
| Hydrochloric Acid SCHEMBL28103558 | 0.77 | MAPT (0.39) | PDE4BMAPTALDH1A1LMNARAB9A | |
| Benzoquinone SCHEMBL20451202 | 0.76 | MAOA (0.58) | MAOAMAOBHSD17B3PDE4BCDC25B | |
| SCHEMBL25835143 | 0.75 | MAPT (0.59) | MAPTPKMRAB9AKMT2APTGS2 | |
| SCHEMBL11575247 | 0.74 | MAOA (0.45) | MAOAMAOBHSD17B3PDE4BCDC25B | |
| SCHEMBL31051316 | 0.74 | IDO1 (0.46) | MAOAMAOBCDC25BIDO1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115093818-B | Electronic grade adhesive and preparation method thereof | 浙江亦龙新材料有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | THE UNIVERSITY OF HONG KONG (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | THE UNIVERSITY OF HONG KONG (CN) | 2023-07-20 | — | — | US | disclosed |
| CN-1181817-C | NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone | ��һ��������ҩ��ʽ���� | 2004-12-29 | — | — | CN | disclosed |
| CN-1262618-A | NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone | SUNTORY LTD (JP) | 2000-08-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | NFE2L2, DUOX1, DUOX2 | MAOA 44/4885MAOB 90/4885HSD17B3 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.